Trilaktan
Therapeutic class:
Antiglaucoma agent – Synthetic analog of prostaglandin F2α
INN
Latanoprost
Market authorization in the following countries
Belarus
Cambodia
Therapeutic class:
Antiglaucoma agent – Synthetic analog of prostaglandin F2α
INN
Latanoprost
Market authorization in the following countries
Belarus
Cambodia